Lantheus expands in neuro and oncology with LMI and Evergreen acquisitions
Lantheus' oncology portfolio includes Pylarify (piflufolastat F 18) and a growing pipeline addressing various solid tumours.
Hosted on MSN1mon
Exploring Dementia in 3D: Techniques and Applications
4 The FDG-PET evaluates glucose metabolism in the brain, PiB-PET employs Pittsburgh compound B for amyloid binding, and AV45-PET utilizes florbetapir for amyloid. The PET scan classifications into ...